ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye…
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,958 per ETH;…
Versos AI Launches the First End-to-End Solution for Preparing and Licensing Video Training Data for AI
SAINT JOHN, New Brunswick, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Versos AI…
GovSignals Achieves DoW IL5 Authorization with Second Front Systems, Bringing Secure Acquisition AI to Defense and Federal Missions
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- GovSignals, the acquisition AI…
AI-focused DreamzTech Solutions named to TIME’s Fastest-Growing Companies 2026 list and Forbes DGEMS 2025 Select 200
KOLKATA, India, Feb. 23, 2026 /PRNewswire/ -- DreamzTech Solutions announced that it…
Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones
Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices…
U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults
Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the…
VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025
February 20, 2026 19:11 ET | Source: VERSES AI Inc. VANCOUVER, British…
Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
February 20, 2026 16:49 ET | Source: Bel Fuse Inc. WEST ORANGE,…
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position…
